Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir in HIV-Infected Subjects
NCT00004584Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 1999
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Dec 1999; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004584.